Aspen Aerogels (ASPN) Expected to Announce Quarterly Earnings on Thursday

Aspen Aerogels (NYSE:ASPN) will likely be issuing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Aspen Aerogels to announce earnings of ($0.09) per share and revenue of $72.07 million for the quarter. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Parties are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The firm had revenue of $49.85 million for the quarter, compared to the consensus estimate of $42.42 million. On average, analysts expect Aspen Aerogels to post ($0.69) EPS for the current fiscal year and ($0.21) EPS for the next fiscal year.

Aspen Aerogels Price Performance

ASPN stock opened at $5.50 on Thursday. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $8.56. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $456.36 million, a P/E ratio of -3.59 and a beta of 3.06. The firm has a 50 day moving average of $5.25 and a 200-day moving average of $4.65.

Insider Activity at Aspen Aerogels

In related news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of the firm’s stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total transaction of $58,086,414.98. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 2.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ASPN. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, September 21st. Roth Capital reiterated a “buy” rating and issued a $7.75 price objective on shares of Aspen Aerogels in a research report on Friday, August 7th. Wall Street Zen lowered Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Barclays boosted their target price on Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 11th. Finally, B. Riley Financial restated a “buy” rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $5.94.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.

Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.